26 results
Search Results
2. GROUPS SEEK MORE FDA FLEXIBILITY IN EARLY CELL THERAPY DEVELOPMENT
3. Cluster of differentiation 8 T-cell population in the laryngeal mucosa of smokers with laryngeal cancer.
4. Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas.
5. Breakthrough T cell discovery has huge potential for engineering custom immune responses.
6. Neon Therapeutics announces publication of study on cancer neoantigens
7. Targeting CD38 in Neoplasms and Non-Cancer Diseases.
8. CAR MACROPHAGES GO BEYOND T CELLS TO FIGHT SOLID TUMORS
9. Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific Neoantigens
10. State of the art in CAR T cell therapy for [CD19.sup.+] B cell malignancies
11. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
12. TEIPP peptides: exploration of unTAPped cancer antigens.
13. The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design.
14. PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois.
15. Findings from Massachusetts General Hospital Update Understanding of Cancer (Defective HLA class I antigen processing machinery in cancer)
16. Vaccine delivers a boost to T cell therapy.
17. City of Hope scientists showcase new findings at the 2019 AACR meeting
18. Tmunity Announces Exclusive License and Research Collaboration with Children's Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma
19. Tmunity Announces Exclusive License and Research Collaboration with Children's Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma
20. Immune therapy takes a 'BiTE' out of brain cancer
21. IMMUNE THERAPY TAKES A 'BITE' OUT OF BRAIN CANCER
22. TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Company's Novel TRuC-T Cells
23. TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Company's Novel TRuC(TM)-T Cells
24. City of Hope Scientists Showcase New Findings at the 2019 AACR Meeting
25. CITY OF HOPE SCIENTISTS SHOWCASE NEW FINDINGS AT THE 2019 AACR MEETING
26. City of Hope Scientists to Release New Findings at the 2019 AACR Meeting
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.